Development of hyperfimbriated strains of Vibrio cholerae O1

Microbiology and Immunology

Volumn 44, Issue 6, 2000, Pages 439-446

  Ehara, Masahiko ^a   Iwami, Mamoru ^a   Ichinose, Yoshio ^a   Hirayama, Toshiya ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cholera vaccine; Hyperfimbriated strain; Overproduction vector; Type 4 fimbriae

Indexed keywords

ARTICLE; BACTERIAL GENE; FIMBRIA; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VIBRIO CHOLERAE;

ESCHERICHIA COLI; VIBRIO CHOLERAE;

EID: 0033918023     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2000.tb02518.x     Document Type: Article

References (28)

1. Chaicunipa, W., Chongsa-nguan, M., Kulambaheti, T., Wilairatana, P., Srimanote, P., Makakunkijcharoen, Y., Looareesuwan, S., and Sakolvaree, Y. 1998. Immunogenicity of liposome-associated and refined antigen oral cholera vaccine in Thai volunteers. Vaccine 16: 678-684.
2. Clemens, J.D., Harris, J.R., Sack, D.A., Chakrahorty, J., Ahmed, F., Stanton, B.F., Khan, M.U., Kay, B.A., Huda, N., Khan, M.R., et al. 1988. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J. Infect. Dis. 158: 60-69.
3. Clemens, J.D., Santon, B.F., Chakrahorty, J., Sack, D.A., Khan, M.R., Huda, S., Ahmed, F., Harris, J.R., Yunus, M. Khan, M.U., et al. 1987. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J. Infect. Dis. 155: 79-85.
4. Coster, T.S., Killeen, K.P., Waldor, M.K., Beattie, D.T. Spriggs, D.R., Kenner, J.R., Trofa, A.., Sadoff, J.C., Mekalanos, J.J., and Taylor, D.N. 1995. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine protype. Lancet 345: 949-952.
5. Davis, L.G., Dibner, M.D., and Battey, J.F. 1986. In Basic methods in molecular biology. Elsevier Science Publishing Co., Inc., New York.
6. Ehara, M. Iwami, M., Ichinose, Y., Hirayama, T., Albert, M.J., Sack, R.B., and Shimodori, S. 1998. Induction of fimbriated Vibrio cholerae O139. Clin. Diagn. Lab. Immunol. 5: 65-69.
7. Ehara, M., Shimodori, S., Kojima, F., Ichinose, Y., Hirayama, T., Albert, M.J., Supuwat, K., Honma, Y. Iwanaga, M., and Amako, K. 1997. Characterization of filamentous phages of Vibrio cholerae O139 and O1. FEMS Microbiol. Lett. 154: 293-301.
8. Ehara, M., Ichinose, Y. Hirayama, T., Kuruzono, H., Hidaka, Y., Morita, K., Igarashi, A., and Shimodori, S. 1994. Cloning and sequencing of the gene encoding Vibrio cholerae O1 fimbrial subunit (fimbrillin). FEMS Microbiol. Lett. 123: 185-192.
9. Ehara, M., Ichinose, Y. Iwami, M., Utsunomiya, A., Shimodori, S., Kangethe, S.K., Neves, B.C., Supawat, K., and Nakamura, S. 1993. Immunogenicity of Vibrio cholerae O1 fimbriae in animal and human cholera. Microhiol. Immunol. 37: 679-688.
10. Ehara, M., Iwami, M., Ichinose, Y. Shimotori, S., Kangethe, S.K., and Nakamura, S. 1991. Purification and characterisation of fimbriae from fimbriate Vibrio cholerae O1 strain Bgd17. Trop. Med. 33: 109-125.
11. Elleman, T.C. 1988. Pilins of Bacteroides nodosus: molecular basis of serotypic variation and relationships toother bacterial pilins. Microbiol. Rev. 52: 233-247.
12. Jonson, G., Lebens, M., and Holmgren, J. 1994. Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes. Mol. Microbiol. 13: 109-118.
13. Jouravleva, E.A., McDonald, O.A., Marsh, J.W., Taylor, R.K., Boesman-Finkelstein, M., and Finkelstein, R.A. 1998. The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139. Infect. Immun. 66: 2535-2539.
14. Kalambaheti, T., Chaisri, U., Srimanote, P., Pongponratn, E., and Chaicumpa, W. 1998. Immunogenicity and protective role of three formulations of oral cholera vaccine. Vaccine 16: 201-207.
15. Kenner, J.R., Coster, T.S., Taylor, D.N., Trofa, A.F., Barrera-Oro, M., Hyman, T., Adams, J.M., Beattie, D.T., Killeen, K.P., Spriggs, D.R., Mekalanos, J.J., and Sadoff, J.C. 1995. Peru-15. an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J. Infect. Dis. 172: 1126-1129.
16. Levine, M.M., Kaper, J.B., Herrington, D., Losonsky, G., Morris, J.G., Clements, M.L., Black, R.E., Tall, B., and Hall, R. 1988. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect. Immun. 56: 161-167.
17. Nakasone, N., Yamashiro, T., Albert, M.J., and Iwanaga, M. 1994. Pili of a Vibrio cholerae O139. Microbiol. Immunol. 38: 225-227.
18. Osek, J., Svennerholm, A.-M., and Holmgren, J. 1992. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili. Infect. Immun. 60: 4961-4964.
19. Qadri, F., Jonson, G., Begnum, YA., Wennerås, C. Albert, M., Salam, M.A., and Svennerholm, A.-M. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 4: 429-434.
20. Sanchez, J.L., Trofa, A.F., Taylor, D.N., Kuschner, R.A., DeFraites, R.F., Craig, S.C., Rao, M.R., Clemens, J.D., Svennerholm, A.-M., Sadoff, J.C., et al. 1993. Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers. J. Infect. Dis. 167: 1446-1449.
21. Shimodori, S., Iida, K., Kojima, F., Takeda, A., Ehara, M., and Amako, K. 1997. Morphological features of a filamentous phage of Vibrio cholerae O139 Bengal. Microbiol. Immunol. 41: 757-763.
22. Stewart, D.J., Clark, B.L., Peterson, J.E., Emery, D.L., Smith, E.F., Griffiths, D.A., and O'Donnel, I.J. 1985. The protection given by pilus and whole cell vaccines of Bacteroides nodosus strain 198 against ovine foot-rot induced by strains of different serogroups. Aust. Vet. J. 62: 153-159.
23. Stewart, D.J., Clark, B.L., Peterson, J.E., Griffiths, D.A., and Smith, E.F. 1982. Importance of pilus-associated antigen in Bacteroides nodosus vaccines. Res. Vet. Sci. 32: 140-147.
24. Strom, M.S., and Lory, S. 1993. Structure-function and biogenesis of the type IV pili. Annu. Rev. Microbiol. 47: 565-596.
25. Tacket, C.O., Kotloff, K.L., Losonsky, G., Nataro, J.P., Michalski, J., Kaper, J.B., Edelman, R., and Levine, M.M. 1997. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. Am. J. Trop. Med. Hyg. 56: 533-537.
26. Tacket, C.O., Losonsky, G., Nataro, J.R. Comstock, L., Michalski, J., Edelman, R., Kaper, J.B., and Levine, M.M. 1995. Initial clinical studies of CVD 112 Vibrio cholerae O1 39 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172: 883-886.
27. Tacket, C.O., Losonsky, G., Nataro, J.P., Cryz, S.J., Edelman, R., Fasano, A., Michalski, J., Kaper, J.B., and Levine, M.M. 1993. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a ΔctxA Δzot Δace derivative of El Tor Ogawa Vibrio cholerae. J. Infect. Dis. 168: 1536-1540.
28. Taylor, D.N., Killeen, K.P., Hack, D.C., Kenner, J.R., Coster, T.S., Beattie, D.T., Ezzell, J. Hyman, T., Trofa, A., Sjogren, M.H., Friedlander, A., Mekalanos, J.J., and Sadoff, J.C. 1994. Development of a live, oral, attenuated vaccine against El Tor cholera. J. Infect. Dis. 170: 1518-1523.